Skip to main content
Premium Trial:

Request an Annual Quote

CapitalBio Tests Certified for Dx Use in China, Europe

NEW YORK (GenomeWeb News) – CapitalBio has been cleared by the Chinese government to use its microarray-based diagnostic tests for autoimmine diseases and it has certified with the CE mark tests for tuberculosis testing in Europe, the company said today.

The Beijing-based diagnostics developer received a certificate from the China State Food and Drug Administration to offer its Antinuclear Antibody Array Test Kits. The certification covers tests for eight different antinuclear antibodies, and it can be used to help diagnose systemic autoimmune diseases including systemic lupus erythematosis, mixed connective tissue disease, Sjögren's syndrome, systemic sclerosis, dermatomyositis, polymyositis, and CREST syndrome, said Capital Bio.

The firm also certified three diagnostic tests for tuberculosis with the CE mark.

One of these microarray-based kits can identify 17 mycobacteria species, which can provide information about an infection and help guide treatment, said Capital Bio. The second kit detects drug resistance in the tuberculosis bacteria and also helps doctors decide a correct treatment course. A third test, which is a real-time PCR-based assay, discriminates between tuberculosis mycobacteria and non-tuberculosis mycobacteria, which doctors could use to choose which microarray assay to use.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.